#111 Discharges with Incidental Findings: Gra...

MASLD affects nearly one in three adults worldwide, yet many patients remain undiagnosed until advanced fibrosis or cirrhosis develops. So, which patients should clinicians actually be screening? When is a FIB-4 enough, and when should we move to elastography or hepatology referr ...  Show more

What blood pressure should we target in patients on hemodialysis? Why volume control remains the foundation of treatment? How blood pressure targets differ from the general population. Learn practical pearls on medication timing around dialysis, drug dialyzability, antihypertensi ...  Show more

At some point during clinical rotations, you’ll be asked about screening guidelines for lung cancer. It’s important to know these for sure, but it’s also important to know what to do if there are any abnormalities after you order that screening. Here, we’ll review the guidelines ...  Show more

Send us Fan MailEver wonder what to do with that finding of an unexpected nodule on chest xray? Here we walk you through the approach including risk stratification, follow-up, and work-up. Written by: Dr. Brandon Luu (Internal Medicine Resident) Reviewed by: Dr. Lee Fidler (Respi ...  Show more

Join us as we discuss patient pathways for OMFS patients. Including a sample report on a theoretical whipple patient (grab your fav report sheet to practice!), common nursing priorities and needs, meds, education, and more.

Show notes are located here: <a href= "https:/ ...

How do you predict which intermediate-risk patients will suddenly deteriorate? What role do risk scores, biomarkers, imaging, and hemodynamics play in decision-making? Should these patients receive anticoagulation alone, or is thrombolysis warranted? When should you consider cath ...  Show more